Literature DB >> 8235293

Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

R Miesel1, M Zuber.   

Abstract

Sera from 354 patients with various inflammatory and autoimmune rheumatic diseases were screened for the presence of reactive nitrogen intermediates, antinuclear antibodies and the anti-oxidase copper-thionein (Cu-thionein), and compared to sera from healthy donors and patients with non-rheumatic diseases including AIDS, various internal as well as neurological diseases and carcinoma of different organs. When compared to healthy individuals, the levels of nitric oxides in sera from patients with autoimmune rheumatic diseases were elevated by 240-600% (P < 0.01). The status of reactive nitrogen intermediates (NOx, RNI) in sera from donors with inflammatory rheumatic diseases was increased by 170-540%, but was also significantly enhanced in sera of patients with non-rheumatic diseases, indicating a general inflammatory mechanism that is predominantly triggered by inducible nitric oxide (NO) syntheses of phagocytes. All rheumatic sera were dramatically depleted of the anti-oxidase Cu-thionein (P < 0.001), a powerful consumer of hydroxyl radicals and singlet oxygen and an efficient superoxide dismutase. The NOx levels were positively correlated with the serum titers of antinuclear antibodies (r = 0.77) and negatively correlated with Cu-thionein levels (r = 0.94), reflecting a high steady-state concentration of free radicals generated during inflammatory and autoimmune rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8235293     DOI: 10.1007/bf00290295

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  63 in total

Review 1.  Nitric oxide, a novel neuronal messenger.

Authors:  D S Bredt; S H Snyder
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

2.  Superoxide-induced deimination of arginine in hematopoietic cells.

Authors:  P P Kamoun; E Schneider; M Dy
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

3.  Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst.

Authors:  R Iyengar; D J Stuehr; M A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens.

Authors:  S Nikkari; R Merilahti-Palo; R Saario; K O Söderström; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1992-06

Review 5.  Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis?

Authors:  J P Banga; A M McGregor
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

6.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

Review 7.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

8.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

9.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures.

Authors:  J J Schroeder; R J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.

Authors:  J D MacMicking; D O Willenborg; M J Weidemann; K A Rockett; W B Cowden
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  8 in total

1.  Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; R Hartung; H Kroeger
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

2.  Effect of late modulation of nitric oxide production on murine lupus.

Authors:  J C Oates; P Ruiz; A Alexander; A M Pippen; G S Gilkeson
Journal:  Clin Immunol Immunopathol       Date:  1997-04

3.  Reactivity of an active center analog of Cu2Zn2superoxide dismutase in murine model of acute and chronic inflammation.

Authors:  R Miesel; R Haas
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

4.  Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

5.  Suppression of arthritis by an active center analogue of Cu2Zn2-superoxide dismutase.

Authors:  R Miesel; A Dietrich; B Brandl; N Ulbrich; M Kurpisz; H Kröger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; L S Tam; C W K Lam
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

7.  Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase.

Authors:  R Miesel; M Kurpisz; H Kröger
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

8.  Antiinflammatory effects of NADPH oxidase inhibitors.

Authors:  R Miesel; D Sanocka; M Kurpisz; H Kröger
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.